Search

Displaying results 9901 - 9910 of 10000 in total
  1. Drug

    Rovadicitinib

    go.drugbank.com/drugs/DB21747
    Investigational

    Rovadicitinib is under investigation in clinical trials NCT06682169 and NCT06300320 for the treatment of Chronic Graft-versus-host Disease.

  2. Drug

    Vezocolmitide

    go.drugbank.com/drugs/DB21751
    Investigational

    Vezocolmitide is under investigation in clinical trial NCT06178679 (Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease

    Synonyms: ST-100
  3. Drug

    XT-150

    go.drugbank.com/drugs/DB21756
    Investigational

    XT-150 is a locally injectable non-viral therapy expressing IL-10v, a proprietary modified variant of IL-10.[L52125] It is being developed by Xalud Therapeutics.

  4. Drug

    Schinus terebinthifolia pollen

    go.drugbank.com/drugs/DB21762
    Approved

    Schinus terebinthifolia pollen is the pollen of the Schinus terebinthifolia plant. Schinus terebinthifolia pollen is mainly used in allergenic testing.

  5. Drug

    Chikungunya virus Senegal strain 37997 capsid protein

    go.drugbank.com/drugs/DB21766
    ApprovedInvestigational

    One of three components of a recombinant Chikungunya virus vaccine called Vimkunya.

  6. Drug

    Chikungunya virus Senegal strain 37997 envelope protein E2

    go.drugbank.com/drugs/DB21768
    ApprovedInvestigational

    One of three components of a recombinant Chikungunya virus vaccine called Vimkunya.

  7. Drug

    Azilsartan

    go.drugbank.com/drugs/DB21772
    Investigational

    Categories: Angiotensin 2 Receptor Blocker, Heterocyclic Compounds, 1-Ring
  8. Drug

    Enlonstobart

    go.drugbank.com/drugs/DB21890
    Investigational

    Enlonstobart is a recombinant and fully-humanized immunoglobulin G4 monoclonal antibody. … [A274486] It targets the programmed cell death protein 1 (PD-1), is being developed by the CSPC Pharmaceutical Group for the treatment of advanced cervical cancer and other solid tumours.

    Synonyms: 恩朗苏拜单抗International brands: 恩舒幸
  9. Drug

    Anti-CD19 CAR-T cells

    go.drugbank.com/drugs/DB21913
    Investigational

    CD19 CAR-T is under investigation in clinical trial NCT05618041 (The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients with Hematological Malignancies).

    Synonyms: CD19 CAR T, CD19 CAR-T
  10. Drug

    Patritumab deruxtecan

    go.drugbank.com/drugs/DB21996
    Investigational

    Patritumab deruxtecan is under investigation in clinical trial NCT06596694 (Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)).